U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07646145) titled 'Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Ri... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645157) titled 'Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression' on June 09. Br... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07646041) titled 'Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cance... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644234) titled 'Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Ac... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644286) titled 'A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiot... Read More
Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled Phase 2 study to investigate the effic... Read More
Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645703) titled 'MS and Health Cohort' on June 09. Brief Summary: This study aims to identify clinical, bio... Read More
Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More